Two new publications provide emergency response agencies with critical insights into commercially available unmanned ground vehicles used for hazardous materials response.
Continued studies will deepen scientists’ understanding of virus-host interactions at the molecular level and also pave the way for developing better drugs to fight emerging viruses.
The Wildfire Mitigation Plan Database was built to support electric utilities, state governments, policymakers, and regulators in understanding and improving wildfire risk and resilience strategies.
The Grid Storage Launchpad dedication event was attended by leaders in grid and transportation energy storage, battery innovation, and industry stakeholders working to transform America’s energy system.
Early life exposure to polycyclic aromatic hydrocarbons (PAHs), found in smoke, has been linked to developmental problems. To study the impacts of these pollutants, PAH metabolism in infants and adults were compared.
Erich Hsieh, Deputy Assistant Secretary for OE’s Energy Storage Division, shared insights about the Grid Storage Launchpad and energy storage innovations .
Discovering and measuring the spatial organization of proteins within cells allows scientists to map complex proteoforms across tissues with near-cellular resolution.
PNNL advisors joined a panel of Washington State emergency management personnel to discuss how partnerships with national laboratories are enabling science and technology solutions.
Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.
Germany Harris, Dewayne Maye, Sarah Olocha, Shaniya Pettway, and Rayonna Redmon became the first interns of the Minority Serving Institution Partnership Program Partnership for Radiation Studies Consortium at PNNL.
COVID-19 infections at PNNL early in the pandemic were caused by a wide variety of viral sequences, according to a new analysis by Laboratory researchers.
Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.